Search results
Found 6789 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Major funding for Oxford will help find new cancer treatments
Awards and Appointments General Research
23 January 2023
Cancer Research UK and the National Institute for Health and Care Research are investing over £3 million across the next five years into The University of Oxford’s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
Daniel Freeman to join Department of Experimental Psychology as Professor of Psychology
Awards and Appointments General
23 January 2023
The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.
New study reveals role of lymphatic system in bone healing
General Research
19 January 2023
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
Vaccination shown to protect against pregnancy complications from COVID-19 Omicron variant
Coronavirus COVID-19 General Research
17 January 2023
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the ‘2022 INTERCOVID Study’ conducted in 41 hospitals across 18 countries.
Oxford to lead international consortium to unlock potential of programmable nucleic acid drugs
Awards and Appointments General
17 January 2023
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded £8m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Significant scale-up investment for three Oxford spinouts
General Innovation
16 January 2023
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Bodleian Update Jan 2023 - Journals and Databases
10 January 2023
Molnupiravir doesn't reduce COVID-19 hospitalisations in high-risk vaccinated people
Clinical Trials General Research
3 January 2023
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
Professor Marian Knight recognised for services to maternal and public health
Awards and Appointments General
31 December 2022
Professor Knight's research focuses on the care and prevention of severe complications of pregnancy and early life and addressing disparities in outcomes for women and babies from different population groups.
Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award
Awards and Appointments General
20 December 2022
A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
Making smiles
General
19 December 2022
Photographer in Residence at Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Pearl Gan's photograph is featured as one of the winners in The Lancet's Highlights 2022. Highlights is The Lancet's annual photography competition and this year's competition focussed on health-related topics.
Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment
General Research
16 December 2022
New research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
Oxford Ebola vaccine manufactured and shipped in record time by SII
General Research
16 December 2022
More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
‘Thinking Family’ when an adult has a serious illness
General Research
15 December 2022
Every day, thousands of parents and grandparents are diagnosed with serious health conditions such as cancer, lung or heart disease. They are then faced with the unenviable task of sharing this information with the children they love.
Director of MRC Brain Network Dynamics Unit appointed
Awards and Appointments General
15 December 2022
From 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
Nearly 1 in 10 young people experience physical pain and suicidality
General Research
14 December 2022
Nearly one in 10 young people are experiencing both persistent physical pain and suicidal feelings, according to a new paper from researchers from the University of Oxford, Cambridge, Oslo (Norway), King’s College London, and the Parc Sanitari Sant Joan de Deu (Spain).
December 2022 - Volunteer Opportunities
13 December 2022
Doctors regularly give ineffective weight loss advice to patients with obesity, study reveals
General Research
13 December 2022
A study published today in 'Family Practice', led by researchers at the University of Oxford, finds that when doctors tell patients living with obesity to lose weight, the guidance they give is generally vague, superficial, and commonly not supported by scientific evidence.
DPUK welcomes government’s £50m investment in MND research
General Research
13 December 2022
Part of this new funding will help the Dementias Platform UK team work with the MND community to translate scientific discoveries into real-world treatments.